...
首页> 外文期刊>Saudi Pharmaceutical Journal >Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait
【24h】

Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait

机译:在科威特二级和三级政府医院工作的药剂师中的药物警戒和药物不良反应报告的知识,态度和做法

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction: Pharmacovigilance (PV) is essential to detect and prevent adverse drug reactions (ADR) after a drug is marketed. However, ADRs are significantly underreported worldwide. Objective: The aims of this study were to document the knowledge, attitude and practices (KAP) of pharmacists toward PV and ADR reporting and to explore the barriers to implementing a fully functional PV program in Kuwait. Material and methods: Pharmacists working at governmental hospitals were asked to complete a paper-based 25-item questionnaire. Results: A total of 414 pharmacists received the questionnaire and 342 agreed to participate, giving a response rate of 82.6%. Most pharmacists were knowledgeable about the concepts of PV (61.5%) and ADRs (72.6%) and the majority (88.6%) was willing to implement ADR reporting in their clinical practice. Despite this positive attitude, only 26.8% of participants had previously reported an ADR and the main reason for underreporting was stated as not knowing how to report (68.9%). Barriers that hinder the implementation of a PV center included lack of cooperation and communication by healthcare professionals and patients (n=62), lack of time and proper management (n=57), lack of awareness of staff and patients (n=48) and no qualified person to report ADRs (n=35). Conclusions: Overall this study shows that hospital pharmacists in Kuwait had good knowledge and positive attitude toward PV and ADRs reporting. However, the majority of them have never reported ADRs. These results suggest that targeted educational interventions and a well-defined policy for ADR reporting may help increase ADR reporting and support the implementation of a fully functional independent PV center in Kuwait.
机译:简介:药物警戒(PV)对于上市后检测和预防药物不良反应(ADR)至关重要。但是,全球范围内ADR的报告严重不足。目的:本研究的目的是记录药剂师对PV和ADR报告的知识,态度和实践(KAP),并探讨在科威特实施功能齐全的PV计划的障碍。材料和方法:要求在政府医院工作的药剂师填写纸质的25项问卷。结果:共有414位药师收到问卷,其中342位同意参加问卷调查,回复率为82.6%。大多数药剂师对PV(61.5%)和ADR(72.6%)的概念有所了解,并且大多数(88.6%)愿意在其临床实践中实施ADR报告。尽管采取了这种积极态度,但只有26.8%的参与者先前曾报告过ADR,而报告不足的主要原因是不知道如何报告(68.9%)。阻碍建立光伏中心的障碍包括:医护人员和患者缺乏合作与沟通(n = 62),缺乏时间和适当的管理(n = 57),员工和患者意识不足(n = 48)没有合格人员举报ADR(n = 35)。结论:总体而言,这项研究表明科威特的医院药剂师对PV和ADR报告具有良好的知识和积极态度。但是,大多数人从未报告过ADR。这些结果表明,针对性的教育干预措施和明确的ADR报告政策可能有助于增加ADR报告并支持在科威特建立功能齐全的独立PV中心。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号